Skip to content
Menu

Barrington Research Maintains Outperform on Dentsply Sirona, Lowers Price Target to $13

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price target from $15 to $13.

Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price target from $15 to $13.

Read at benzinga.com

← All stock news